During the past decade, Kliniken Beelitz GmbH conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Kliniken Beelitz GmbH" are "Parkinson's Disease" (2 trials) and "Complications; Catheter, Urinary (Indwelling Catheter) (Suprapubic)" (1 trials). Many other conditions were trialed in "Kliniken Beelitz GmbH" in a lesser frequency.

Most popular intervention types in "Kliniken Beelitz GmbH" are "Drug" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "E2007" (1 trials), "ND0612" (1 trials) and "Uro-Tainer Polihexanide 0.02%" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kliniken Beelitz GmbH" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Kliniken Beelitz GmbH". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Kliniken Beelitz GmbH, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Kliniken Beelitz GmbH, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".